These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

414 related items for PubMed ID: 29492965

  • 21. Prediction of clinical benefit from androgen deprivation therapy in salivary duct carcinoma patients.
    van Boxtel W, Verhaegh GW, van Engen-van Grunsven IA, van Strijp D, Kroeze LI, Ligtenberg MJ, van Zon HB, Hendriksen Y, Keizer D, van de Stolpe A, Schalken JA, van Herpen CM.
    Int J Cancer; 2020 Jun 01; 146(11):3196-3206. PubMed ID: 31745978
    [Abstract] [Full Text] [Related]

  • 22. Clinical and immunohistologic typing of salivary duct carcinoma: a report of 50 cases.
    Jaehne M, Roeser K, Jaekel T, Schepers JD, Albert N, Löning T.
    Cancer; 2005 Jun 15; 103(12):2526-33. PubMed ID: 15900577
    [Abstract] [Full Text] [Related]

  • 23. Clinicopathologic study of salivary duct carcinoma and the efficacy of androgen deprivation therapy.
    Yamamoto N, Minami S, Fujii M.
    Am J Otolaryngol; 2014 Jun 15; 35(6):731-5. PubMed ID: 25087467
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A randomized phase II trial on the addition of dutasteride to combined androgen blockade therapy versus combined androgen blockade therapy alone in patients with advanced or metastatic salivary duct carcinoma - the DUCT study protocol.
    Weijers JAM, Verhaegh GW, Lassche G, van Engen-van Grunsven ACH, Driessen CML, van Erp NP, Jonker MA, Schalken JA, van Herpen CML.
    BMC Cancer; 2024 Sep 20; 24(1):1174. PubMed ID: 39304797
    [Abstract] [Full Text] [Related]

  • 29. Aggressive invasive micropapillary salivary duct carcinoma of the parotid gland.
    Yamamoto H, Uryu H, Segawa Y, Tsuneyoshi M.
    Pathol Int; 2008 May 20; 58(5):322-6. PubMed ID: 18429833
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Androgen deprivation therapy for androgen receptor-positive advanced salivary duct carcinoma: A nationwide case series of 35 patients in The Netherlands.
    Boon E, van Boxtel W, Buter J, Baatenburg de Jong RJ, van Es RJJ, Bel M, Fiets E, Oosting SF, Slingerland M, Hoeben A, Tesselaar MET, Jonker MA, Flucke UE, Nationwide Network and Registry of Histopathology and Cytopathology (PALGA) Group, van der Graaf WTA, van Herpen CML.
    Head Neck; 2018 Mar 20; 40(3):605-613. PubMed ID: 29272069
    [Abstract] [Full Text] [Related]

  • 32. Salivary duct carcinomas can be classified into luminal androgen receptor-positive, HER2 and basal-like phenotypes.
    Di Palma S, Simpson RH, Marchiò C, Skálová A, Ungari M, Sandison A, Whitaker S, Parry S, Reis-Filho JS.
    Histopathology; 2012 Oct 20; 61(4):629-43. PubMed ID: 22882517
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Intraoral salivary duct carcinoma: a clinicopathological study of four cases and review of the literature.
    Epivatianos A, Dimitrakopoulos J, Trigonidis G.
    Ann Dent; 1995 Oct 20; 54(1-2):36-40. PubMed ID: 8572543
    [Abstract] [Full Text] [Related]

  • 36. Expression of mitotic checkpoint proteins BUB1B and MAD2L1 in salivary duct carcinomas.
    Ko YH, Roh JH, Son YI, Chung MK, Jang JY, Byun H, Baek CH, Jeong HS.
    J Oral Pathol Med; 2010 Apr 20; 39(4):349-55. PubMed ID: 20040022
    [Abstract] [Full Text] [Related]

  • 37. [Salivary duct carcinoma--a clinicopathological analysis of five cases].
    Bień S, Sygut J, Kopczyński J, Postuła S, Ziółkowska M.
    Otolaryngol Pol; 2007 Apr 20; 61(1):33-8. PubMed ID: 17605416
    [Abstract] [Full Text] [Related]

  • 38. Successful multimodal treatment of intraoral salivary duct carcinoma in a patient with multiple lymph node metastases: a case report.
    Imaue S, Tomihara K, Hamashima T, Tomizawa G, Nomura K, Sasahara M, Noguchi M.
    World J Surg Oncol; 2017 Jan 10; 15(1):18. PubMed ID: 28073374
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.